Summary
- Current Price
- As of today, ELAN price is $23.61, up +4.89% on
- Current Price All-Time High
- ELAN price is currently -37.22% below its historical high of $37.61 set on
- Market Cap
- ELAN current market cap is $12B, up +31.95% over the past 365 days
- Revenue
- ELAN current annual revenue is $4.72B, up +6.22% year-over-year
- Next Earnings
- The next earnings release for ELAN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Elanco Animal Health Incorporated |
| Ticker | NYSE: ELAN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | elanco.com |
| Employees | 9,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $23.61 | |
| Price, 1D Change | +4.89% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.35 | |
| Revenue | $4.72B | |
| Revenue, 1Y Change | +6.22% | |
| EPS | -$0.47 | |
| EPS, 1Y Change | -168.77% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$0.47 | |
| EPS Estimate | $1.13 | N/A |
| EPS Est. Change | +341.19% | N/A |
| Revenue | $4.72B | |
| Revenue Estimate | $5.12B | N/A |
| Revenue Est. Change | +8.62% | N/A |
| Current Price | $23.61 | |
| Price Target | $31.50 | - |
| Price Tgt. Change | +33.42% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.92 | $0.68 | -25.78% | |
| $0.94 | -$0.47 | -149.69% | |
| $1.13 | N/A | +341.19% | |
| $1.26 | N/A | +370.43% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.43B | $4.44B | +0.18% | |
| $4.67B | $4.72B | +0.97% | |
| $5.12B | N/A | +8.62% | |
| $5.39B | N/A | +14.40% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +31.17% | |
| Price, 3Y | +96.75% | |
| Market Cap, 1Y | +31.95% | |
| Market Cap, 3Y | +99.57% | |
| Revenue, 1Y | +6.22% | |
| Revenue, 3Y | +6.89% | |
| EPS, 1Y | -168.77% | |
| EPS, 3Y | -192.67% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $23.61 | |
| SMA 200 | $23.58 | |
| SMA 50 | $24.56 | |
| EMA 200 | $22.76 | |
| EMA 50 | $24.33 | |
| MACD | -$0.49 | |
| Beta | 1.35 | |
| ATR | $1.13 | |
| 14-Day RSI | 44.69 | |
| 10-Day Volatility | 68.10% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $4.72B | |
| EPS | -$0.47 | |
| Gross Profit | $2.05B | |
| Gross Margin | 43.48% | |
| Operating Income | $252.00M | |
| Operating Margin | 5.34% | |
| Net Income | -$232.00M | |
| Net Margin | -4.92% | |
| EBITDA | $932.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.63 | |
| 2.17 | ||
| 1.08 | ||
| - | ||
| 5 | ||
| 1.39 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 2.35 | ||
| 1.79 | ||
| 14.80 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $6.55B | |
| $545.00M | ||
| $13.36B | ||
| $3.46B | ||
| $6.81B | ||
| $1.60B | ||
| Total Debt | $4.14B | |
| $112.00M | ||
| $368.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $4.95B | ||
| $1.80B | ||
| $2.67B | ||
| $0.00 | ||
| $680.00M | ||
| $0.00 | ||
| $8.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $560.00M | ||
| -$279.00M | ||
| -$275.00M | ||
| Capex | $276.00M | |
| $284.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Keybanc | → | |
| Morgan Stanley | → | |
| TD Cowen | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Citigroup | ||
| Morgan Stanley | → | |
| Keybanc | → | |
| Leerink Partners | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ELAN
FAQ
- What is the ticker symbol for Elanco Animal Health Incorporated?
- The ticker symbol for Elanco Animal Health Incorporated is NYSE:ELAN
- Does Elanco Animal Health Incorporated pay dividends?
- No, Elanco Animal Health Incorporated does not pay dividends
- What sector is Elanco Animal Health Incorporated in?
- Elanco Animal Health Incorporated is in the Healthcare sector
- What industry is Elanco Animal Health Incorporated in?
- Elanco Animal Health Incorporated is in the Specialty & Generic Drug Manufacturers industry
- What country is Elanco Animal Health Incorporated based in?
- Elanco Animal Health Incorporated is headquartered in United States
- When did Elanco Animal Health Incorporated go public?
- Elanco Animal Health Incorporated initial public offering (IPO) was on September 20, 2018
- Is Elanco Animal Health Incorporated in the S&P 500?
- No, Elanco Animal Health Incorporated is not included in the S&P 500 index
- Is Elanco Animal Health Incorporated in the NASDAQ 100?
- No, Elanco Animal Health Incorporated is not included in the NASDAQ 100 index
- Is Elanco Animal Health Incorporated in the Dow Jones?
- No, Elanco Animal Health Incorporated is not included in the Dow Jones index
- When was Elanco Animal Health Incorporated last earnings report?
- Elanco Animal Health Incorporated's most recent earnings report was on August 5, 2026
- When does Elanco Animal Health Incorporated report earnings?
- The next expected earnings date for Elanco Animal Health Incorporated is November 5, 2026
Data Sources & References
- ELAN Official Website www.elanco.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1739104/000173910426000012/0001739104-26-000012-index.htm
- ELAN Profile on Yahoo Finance finance.yahoo.com/quote/ELAN
- ELAN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elan